Clinical Trial Update: Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating fluorodeoxyglucose F-18 PET imaging for early detection of residual disease after radiofrequ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colorectal Cancer

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Colorectal Cancer, Metastatic Cancer | NA | Status: COMPLETED